A detailed history of Israel Englander (Millennium Management LLC) transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,696,524 shares of XERS stock, worth $5.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,696,524
Previous 1,695,753 0.05%
Holding current value
$5.67 Million
Previous $3.75 Million 1.87%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.7 - $2.45 $1,310 - $1,888
771 Added 0.05%
1,696,524 $3.82 Million
Q1 2024

May 15, 2024

BUY
$2.04 - $3.22 $301,507 - $475,909
147,798 Added 9.55%
1,695,753 $3.75 Million
Q4 2023

Feb 14, 2024

SELL
$1.47 - $2.36 $385,716 - $619,245
-262,392 Reduced 14.49%
1,547,955 $3.64 Million
Q2 2023

Aug 14, 2023

BUY
$1.82 - $2.98 $3.29 Million - $5.39 Million
1,810,347 New
1,810,347 $4.74 Million
Q4 2022

Feb 14, 2023

BUY
$1.14 - $1.65 $791,209 - $1.15 Million
694,043 New
694,043 $923,000

Others Institutions Holding XERS

About Xeris Biopharma Holdings, Inc.


  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $454M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.